top of page
Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB
Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...
The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Automation in Talent Attraction: fighting candidate pre-conditioning.
How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...
Search
RadNet to acquire iCAD for $103M to advance AI-powered breast cancer detection worldwide
Los Angeles, CA and Nashua, NH, April 15, 2025 (Globe Newswire) -- RadNet will acquire iCAD for approximately $103 million in an...
Galapagos appoints Henry Gosebruch as Founding CEO of SpinCo amid strategic corporate separation
Mechelen, Belgium, and Boston MA, April 21, 2025 (Globe Newswire) -- Galapagos NV appointed Henry Gosebruch as founding CEO of its...
Glycomine raises $115M to advance first-in-class PMM2-CDG therapy GLM101 into Phase 2b trial
San Carlos, CA, April 16, 2025 (Glycomine) -- Glycomine has secured $115 million in Series C financing to fund a Phase 2b trial of...
Calidi Biotherapeutics appoints Eric Poma as CEO to lead next phase of cancer virotherapy development
San Diego, CA, April 23, 2025 (Globe Newswire) -- Eric Poma, Ph.D., has been appointed CEO of Calidi Biotherapeutics, succeeding Allan...
Repertoire partners with Genentech in $765M deal to develop T cell-targeted autoimmune therapies
Cambridge, MA, April 22, 2025 (PRNewswire) -- Repertoire Immune Medicines has entered into a strategic partnership with Genentech to...
AIRNA Raises $155M to Advance RNA Editing Therapy for Genetic Lung and Liver Disease
Cambridge, MA and Tubingen, Germany, April 6, 2025 (Business Wire) -- AIRNA secured $155 million in an oversubscribed Series B to...
Phathom Pharmaceuticals Appoints Steven Basta as CEO to Accelerate Commercial Growth
Florham Park, NJ, April 1, 2025 (Globe Newswire) -- Steven Basta, a seasoned executive with over 25 years of industry leadership, has...
CMR Surgical Secures $200M to Launch Versius Robot in U.S. Market
Cambridge, UK, April 2, 2025 (yahoo finance) -- CMR Surgical closed a $200 million+ funding round to support the global...
Enovis Appoints Damien McDonald as CEO to Lead Next Phase of Growth
Wilmington, DE, April 2, 2025 (Globe Newswire) -- Enovis has named Damien McDonald as CEO, effective May 12, 2025, as Matt Trerotola...
Isomorphic Labs Secures $600M to Transform Drug Discovery with AI
London, March 31, 2025 (Reuters) -- Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital....
Curevo secures $110M series B to advance Amezosvatein Shingles Vaccine
Seattle, WA, March 17, 2025 (Globe Newswire) -- Curevo Vaccine, a clinical-stage biotechnology company specializing in varicella zoster...
Akari Therapeutics appoints Abizer Gaslightwala as President and CEO
Boston and London, March 20, 2025 (Globe Newswire) -- Akari Therapeutics has named Abizer Gaslightwala as its new President and CEO,...
Latigo Biotherapeutics secures $150M series B to advance non-opioid pain treatments
Thousands Oak, CA, March 17, 2025 (PRNewswire) -- Latigo Biotherapeutics, a clinical-stage biotechnology company, has successfully...
David Pacitti departs Siemens Healthineers to lead Avanos Medical as CEO
Alpharetta, GA, March 17, 2025 (PRNewswire) -- David Pacitti is leaving Siemens Healthineers to become CEO of Avanos Medical after...
AstraZeneca to Acquire EsoBiotec for Up to $1B to Enhance Cancer Cell Therapy Capabilities
Cambridge, UK, March 17, 2025 (Reuters) -- AstraZeneca has announced its agreement to acquire Belgium-based biotechnology firm...
Gensaic and Novo Nordisk Forge $354M Partnership to Advance Precision Therapies
Cambridge, MA, March 3, 2025 (Business Wire) -- Gensaic and Novo Nordisk have formed a collaboration worth up to $354 million per...
Openwater Names Aaron Timm as CEO to Drive Growth in Portable Imaging and Therapy Devices
San Francisco, CA, March 6, 2025 (Business Wire) -- Openwater has named Aaron Timm as CEO to lead its expansion in portable medical...
AbbVie Enters Obesity Drug Race with $2.25B Licensing Deal for Gubra’s Amylin Analog
Chicago, IL, March 3, 2025 (finance yahoo) -- AbbVie has partnered with Gubra in a deal worth up to $2.25 billion to develop an amylin...
Nimbus Therapeutics Appoints Abbas Kazimi as CEO Amid Strategic Transition
Boston, MA, March 7, 2025 (Business Wire) -- Nimbus Therapeutics has appointed Abbas Kazimi as CEO, succeeding Jeb Keiper in a planned...
Roche Strikes $5.3B Deal with Zealand Pharma to Expand in Obesity Market
Basel, Switzerland, March 12, 2025 (Reuters) -- Roche has acquired rights to Zealand Pharma’s obesity drug petrelintide in a deal worth...
bottom of page